Boston Financial Mangement LLC Sells 1,967 Shares of Waters Co. (NYSE:WAT)

Boston Financial Mangement LLC decreased its position in Waters Co. (NYSE:WAT) by 2.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,158 shares of the medical instruments supplier’s stock after selling 1,967 shares during the quarter. Boston Financial Mangement LLC owned approximately 0.14% of Waters worth $30,288,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of WAT. Itau Unibanco Holding S.A. acquired a new position in Waters during the 2nd quarter worth $33,000. Blue Trust Inc. grew its holdings in Waters by 190.2% in the 2nd quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock valued at $35,000 after buying an additional 78 shares during the last quarter. TFC Financial Management Inc. increased its position in Waters by 19,900.0% in the 2nd quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock worth $58,000 after buying an additional 199 shares during the period. Federated Hermes Inc. bought a new position in Waters in the 2nd quarter worth approximately $59,000. Finally, Fidelis Capital Partners LLC acquired a new position in shares of Waters during the first quarter worth approximately $72,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Stock Performance

Waters stock opened at $325.51 on Tuesday. The firm has a market capitalization of $19.32 billion, a P/E ratio of 32.42, a P/E/G ratio of 6.38 and a beta of 0.95. The stock has a fifty day moving average price of $341.86 and a two-hundred day moving average price of $324.72. Waters Co. has a 52-week low of $234.04 and a 52-week high of $367.21. The company has a debt-to-equity ratio of 1.42, a current ratio of 2.10 and a quick ratio of 1.42.

Waters (NYSE:WAT) last announced its earnings results on Wednesday, July 31st. The medical instruments supplier reported $2.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.55 by $0.08. The business had revenue of $709.00 million during the quarter, compared to analysts’ expectations of $700.09 million. Waters had a net margin of 20.71% and a return on equity of 56.81%. The firm’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same quarter last year, the company posted $2.80 EPS. As a group, analysts anticipate that Waters Co. will post 11.6 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

WAT has been the topic of a number of research reports. TD Cowen boosted their target price on shares of Waters from $325.00 to $363.00 and gave the stock a “hold” rating in a research report on Thursday, August 1st. Leerink Partners upgraded shares of Waters from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $325.00 to $375.00 in a report on Thursday, August 1st. Cfra set a $389.00 target price on shares of Waters in a research note on Thursday, October 17th. Deutsche Bank Aktiengesellschaft lowered their price target on Waters from $330.00 to $310.00 and set a “hold” rating on the stock in a research note on Thursday, August 1st. Finally, Evercore ISI raised their price objective on Waters from $335.00 to $355.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Waters currently has a consensus rating of “Hold” and an average target price of $342.58.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.